Compositions and methods for promoting nerve regeneration
CA 2377918 A1 · Owner: Oregon Health Sciences University · Inventors: Gold, Bruce G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Neurite outgrowth and nerve regeneration are promoted by disruption of the steroid receptor complex and stimulation of MAP kinase/kinase activity. This disruption can take the form of disruption of the physical assembly or function of the steroid receptor complex such as the mature complex or a , precursor of the mature complex that is required for assembly of the mature complex. Geldanamycin and its analogs, bastadin and members of the bastadin family, and radicicol and its analogs, as well as FKBP-52 antibody are shown , to disrupt the complex and promote nerve growth. Assays for finding neurotrophic compounds, as well as compounds found by these assays pharmaceutical compositions …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 7, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 7, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 7, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.